MedTrace Logo

Ocular-hypertensive Response to Topical Steroids in Children After Bilateral Strabismus Surgery

NCT02816905 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-06-29

No results posted yet for this study

Summary

This study aims to compare the effects of topical (Rimexolone versus Dexamethasone) on the IOP in children under 13 years of age who underwent bilateral strabismus surgery, and to compare the effects of topical (Rimexolone versus Fluorometholone) on the IOP in the children under 13 years of age who underwent bilateral strabismus surgery.

Conditions

  • Intraocular Pressure

Interventions

DRUG

0.1 % Dexamethasone

20 eyes are randomized to receive topical 0.1% Dexamethasone four times per day for 2 weeks.

DRUG

0.1% Fluorometholone

20 eyes are randomized to receive topical 0.1% Fluorometholone four times per day for 2 weeks.

DRUG

1% Rimexolone

40 eyes are randomized to receive topical 1% Rimexolone four times per day for 2 weeks. 20 of these eyes were the contralateral eyes of the patients who received 0.1% Dexamethasone in their first eye. The other 20 eyes were the contralateral eyes of the patients who received 0.1% Fluorometholone in their first eye

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Omar M. El Shafie El Zawahry, PhD · Cairo University Hospital- Department of Ophthalmology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02816905 on ClinicalTrials.gov